Skip to content

Orifarm Belgium

Active Private limited companyfounded 2019active for 7 yearsGaston Crommenlaan 8, 9050 GhentKBO/BCE: BE 0736.472.401 subsidiary of

Lifetime

6 annual accounts with figures on one time axis
peak of €1.1m in 2025
€1.1m▲ 40.3%
peak of €377,447 in 2025
€377,447▲ 116%
peak of €729,475 in 2025
€729,475▲ 107%
€4.3m▼ 20.8%
peak of 2.8 FTE in 2025
2.8 FTE▲ 33.3%
Board8 names since 2019
4 directors and 3 others
Owners2 names in the annual accounts
consolidates
Documentsfilings and deeds
06-07-202625 days before the deadline
2025abbreviated format
Gross margin from €779,664 to €1.1mResult from €175,053 to €377,447Staff from 2.1 FTE to 2.8 FTE3 directors appointed, 1 resignation 16-12Equity from €352,028 to €729,475Debts from €5.4m to €4.3m

Key points

from the 2025 annual accounts

Equity

€729,475 ▲ 107%

Orifarm Belgium has made a profit in every financial year since 2020.

Result

€377,447 ▲ 116%
€175,0002024€377,0002025

The result rose in 2025 from €175,053 to €377,447.

Debts

€4.3m 85% of the balance sheet
Suppliers 39%Taxes and wages 7%Other 54%

Of this, €1.9m falls due within a year.

Liquidity

2.37 was 1.33 in 2024

Short-term debts fell from €4.0m to €1.9m.

Filings

6 annual accounts 4 late
AprilJune31 JulyOctober202020222024

The 2021 accounts came in latest, 190 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,715 companies had the same profile as Orifarm Belgium has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,715 companies, not a prediction for Orifarm Belgium. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 16-10-2019
Director, since 24-06-2025
Director, since 24-06-2025
Director, since 21-10-2025
Auditor,
  • consolidatesannual accounts 2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0736472401
3 directors appointed, 1 resignation resigns · , and appointed · General meeting of 21-10-2025 · Gazette deed
reappointed as statutory auditor acts as permanent representative · General meeting of 17-07-2024 · Gazette deed
appointed as statutory auditor acts as permanent representative · General meeting of 02-06-2021 · Gazette deed
All 20 events

Comparable companies

same main activity, similar in size and age
Company
Orifarm Belgium Ghent €5.0m €1.1m 14.6% 2.8
AAGATO MEDICAL Ghent €3.9m €1.4m 28.6% 5.8
LIFEXA Schaerbeek €2.9m €0.8m 49.5% 4.8
PAMSANTE BENELUX Brussels €2.4m €1.1m 34.9% 4
Veka Medical Londerzeel €6.8m €0.8m 46.3% 5.6
MOTION MEDICAL Sint-Genesius-Rode €7.1m €0.8m 52.1% 5.5
ISIS MEDICAL Braine-l'Alleud €4.3m €1.7m 33.3% 6.3

These companies have the same main activity as Orifarm Belgium: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €2.4m and €7.1m, founded between 2017 and 2020.

Official details

Source: KBO
Status
Active since 16-10-2019Normal situation
Registered office
82 active companies are registered at this address6 started in the 12 months before. Source: KBO register, as of 18 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committee
207White-collar workers in the chemical industry · annual accounts 2025
Establishment unit
2.296.760.7539050 Ghent, registered on 16-10-2019
Financial year end
31 December
Peppol
Reachable since 11-06-2026
Company details

Annual accounts 2025

≈ €4.5mestimated
€5.0m▼ 12.9%
Employeeson 31-12-2025
3=
Filing
Filed on 06-07-2026, 25 days before the end of the filing period
Financials

Insights on Orifarm Belgium

Orifarm Belgium files the abbreviated format. That format states no turnover. The gross margin rose from €205,708 in 2020 to €1.1m in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Orifarm Belgium

What is the company number of Orifarm Belgium?
The company number of Orifarm Belgium is 0736.472.401. The VAT number is the same number with BE in front: BE 0736.472.401.
Where is Orifarm Belgium based?
The registered office is at Gaston Crommenlaan 8, 9050 Ghent.Company details
What does Orifarm Belgium do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Orifarm Belgium?
Orifarm Belgium is a private limited company (BV).
When was Orifarm Belgium founded?
Orifarm Belgium was founded on 16-10-2019.
Is Orifarm Belgium still active?
Yes, Orifarm Belgium is an active enterprise in the KBO register.
How many employees does Orifarm Belgium have?
Orifarm Belgium had an average of 2.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Orifarm Belgium fall under?
In its 2025 annual accounts, Orifarm Belgium states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of Orifarm Belgium?
The turnover in financial year 2025 is ≈ €4.5m. This figure is estimated from the gross margin of €1.1m and 96 comparable companies (NACE 46). It probably lies between €2.7m and €7.6m.
Is Orifarm Belgium profitable?
In financial year 2025, Orifarm Belgium made a profit of €377,447.
Where can I find the annual accounts of Orifarm Belgium?
Orifarm Belgium filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Orifarm Belgium due?
Orifarm Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.